Clinical trials for the implantable artificial kidney haven’t started yet, but the device’s developers are already seeking feedback from patients. The device, currently in preclinical trials, uses microchip filters and living kidney cells that would be powered by a patient’s own heart. It is being developed by the Kidney Project, a collaboration between the University of California at San Francisco and Vanderbilt University. In March, they announced a partnership with Home Dailyzors United (HDU), who will help provide education and support to patients, as well as seek feedback on preferences.
“The Kidney Project is really interested in the patient voice, they want the patient perspective,” said Nieltje Gedney, vice president of HDU. She and HDU president Denise Eilers first met UCSF bioengineer Shuvo Roy, PhD, technical director of the project, at a Kidney Health Initiative meeting.
“When I first met them, I was struck by their passion for improving the outcomes of home dialysis patients,” said Roy. Working with them seemed like a natural move as they began looking for input from patients, he said.
“When we undertake any project, we are looking at the end result and the goal is quality of life, and this is what excited us the most,” said Eilers. “Shuvo and his team are dedicated to reaching those goals. And every step of the way they are committed to incorporating patient feedback, which is important because patients will be affected by this device the most.”